Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Landscape of circulating tumour DNA in metastatic breast cancer

EBioMedicine(2020)10.1016/j.ebiom.2020.102914Source: DataRank Database

Landscape of circulating tumour DNA in metastatic breast cancer is a research paper published in EBioMedicine (2020). On theSindex it has a DataRank of 1.8. It has been cited 69 times, with 46 citing works in its 1-hop citation network.

N/A

1.8DataRank · unranked

Scored on demand from live citation data

Open Access69 citations · 46 citing works in its network

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 3.53)OA: goldTopics (79)Linked Datasets (12)DataCite Reuse (12)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 35%Citation Network 65%

Base Score Contribution

0.637

From this paper's citation signal

Citation Network Contribution

1.2

From 39 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 46 citers.

Current Triple-Negative Breast Cancer Subtypes: Dissecting the Most Aggressive Form of Breast Cancer
Frontiers in Oncology2021196 citations63 referencesContributes 0.084
Early, On-Treatment Levels and Dynamic Changes of Genomic Instability in Circulating Tumor DNA Predict Response to Treatment and Outcome in Metastatic Breast Cancer Patients
Cancers202111 citations30 referencesContributes 0.083
Circulating Tumor DNA and Survival in Metastatic Breast Cancer
JAMA Network Open202445 citations60 referencesContributes 0.064
The methylation level of TFAP2A is a potential diagnostic biomarker for retinoblastoma: an analytical validation study
PeerJ202110 citations38 referencesContributes 0.063
Olaparib Use in Patients With Metastatic Breast Cancer Harboring Somatic BRCA1/2 Mutations or Mutations in Non-BRCA1/2, DNA Damage Repair Genes
Clinical Breast Cancer202115 citations45 referencesContributes 0.062

Authors (13)

Saya Jacob ORCID,Lorenzo Gerratana ORCID,Ami N. Shah ORCID,Firas Wehbe ORCID,Neelima Katam

Live enrichment

PubMed:32707446 PMC:PMC7381501 OpenAlex:https://openalex.org/W3044254950

National Institutes of Health

Grant: 3OT3TR002020-01S2

Biomedical Data Translator Technical Feasibility Assessment and Architecture Design

National Institutes of Health

Grant: 5UL1TR001422-04

Northwestern University Clinical and Translational Science Institute (NUCATS)

FWCI

3.53

Citation Percentile

1.0%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttp://www.thelancet.com/article/S2352396420302899/pdf

publisherhttp://www.thelancet.com/article/S2352396420302899/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2352396420302899?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2352396420302899?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.ebiom.2020.102914

Fields of Study

Cancer Genomics and DiagnosticsCancer Cells and MetastasisBreast Cancer Treatment Studies0301 basic medicine03 medical and health sciences0303 health sciencesAdultAgedBreast NeoplasmsCirculating Tumor DNADNA Copy Number VariationsFemaleGene FrequencyGene Regulatory NetworksGenetic HeterogeneityHigh-Throughput Nucleotide SequencingHumansMiddle AgedNeoplasm MetastasisPolymorphism, Single NucleotideSequence Analysis, DNA

MeSH Terms

Circulating Tumor DNAAdultAgedBreast NeoplasmsFemaleGene FrequencyHumansMiddle AgedNeoplasm MetastasisSequence Analysis, DNAGenetic HeterogeneityPolymorphism, Single NucleotideGene Regulatory NetworksDNA Copy Number VariationsHigh-Throughput Nucleotide Sequencing

Keywords

Breast cancerMetastatic breast cancerMedicineOncologyCancerInternal medicineTumour heterogeneityCopy-number variationSingle-nucleotide polymorphismDigital polymerase chain reactionTriple-negative breast cancerAlleleGenotypeCancer researchBiologyGeneticsGenomeGenePolymerase chain reactionGenomicsNext-generation SequencingCell-free DnaCirculating Tumour DnaAdultMedicine (General)Research paperDNA Copy Number Variationscell-free DNA; Circulating tumour DNA; Genomics; Metastatic breast cancer; Next-generation sequencingBreast NeoplasmsPolymorphism, Single NucleotideCirculating Tumor DNAGenetic HeterogeneityR5-920Gene FrequencyHumansGene Regulatory NetworksNeoplasm MetastasisAgedRHigh-Throughput Nucleotide SequencingSequence Analysis, DNAMiddle AgedFemale

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Additional file 1 of Interplay between ESR1/PIK3CA codon variants, oncogenic pathway alterations and clinical phenotype in patients with metastatic breast cancer (MBC): comprehensive circulating tumor DNA (ctDNA) analysis

10.6084/m9.figshare.26621950.v1figshare

10.6084/m9.figshare.26621950figshare

Additional file 2 of Identification of mutation patterns and circulating tumour DNA-derived prognostic markers in advanced breast cancer patients

10.6084/m9.figshare.19766124figshare

Additional file 2 of Identification of mutation patterns and circulating tumour DNA-derived prognostic markers in advanced breast cancer patients

10.6084/m9.figshare.19766124.v1figshare

Additional file 4 of Identification of mutation patterns and circulating tumour DNA-derived prognostic markers in advanced breast cancer patients

10.6084/m9.figshare.19766130figshare

Additional file 5 of Identification of mutation patterns and circulating tumour DNA-derived prognostic markers in advanced breast cancer patients

10.6084/m9.figshare.19766133figshare

Additional file 3 of Identification of mutation patterns and circulating tumour DNA-derived prognostic markers in advanced breast cancer patients

10.6084/m9.figshare.19766127.v1figshare

Additional file 3 of Identification of mutation patterns and circulating tumour DNA-derived prognostic markers in advanced breast cancer patients

10.6084/m9.figshare.19766127figshare

Additional file 1 of Identification of mutation patterns and circulating tumour DNA-derived prognostic markers in advanced breast cancer patients

10.6084/m9.figshare.19766121.v1figshare

Additional file 4 of Identification of mutation patterns and circulating tumour DNA-derived prognostic markers in advanced breast cancer patients

10.6084/m9.figshare.19766130.v1figshare

Additional file 1 of Identification of mutation patterns and circulating tumour DNA-derived prognostic markers in advanced breast cancer patients

10.6084/m9.figshare.19766121figshare

Additional file 5 of Identification of mutation patterns and circulating tumour DNA-derived prognostic markers in advanced breast cancer patients

10.6084/m9.figshare.19766133.v1figshare

Related Papers (2)

Single-cell RNA-sequencing reveals distinct patterns of cell state heterogeneity in mouse models of breast cancer

N/A

2.2DataRank · unranked

eLife(2020)

co-cited

10.7554/elife.58810

The genomic landscape of metastasis in treatment-naïve breast cancer models

N/A

0.964DataRank · unranked

PLoS Genetics(2020)

co-cited

10.1371/journal.pgen.1008743